MAK — MATERNUS-Kliniken-AG Income Statement
0.000.00%
- €25.79m
- €202.71m
- €102.31m
- 59
- 90
- 10
- 52
Annual income statement for MATERNUS-Kliniken-AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 124 | 114 | 111 | 107 | 102 |
Cost of Revenue | |||||
Gross Profit | 103 | 97.7 | 97.5 | 87 | 87.4 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 127 | 113 | 108 | 116 | 108 |
Operating Profit | -2.76 | 1.55 | 3.76 | -9.35 | -5.29 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -12.6 | -7.78 | -1.96 | -12.8 | -12.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | -10.3 | -9.62 | -2.48 | -14.1 | -14.3 |
Net Income Before Extraordinary Items | |||||
Net Income | -10.3 | -9.62 | -2.48 | -14.1 | -14.3 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -10.3 | -9.62 | -2.48 | -14.1 | -14.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.489 | -0.459 | -0.078 | -0.671 | -0.68 |
Dividends per Share |